ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,085,000 | -67.9% | 54,071 | -72.9% | 0.02% | -76.6% |
| Q2 2020 | $18,979,000 | +73.3% | 199,218 | +63.5% | 0.09% | +5.6% |
| Q1 2020 | $10,952,000 | +384.2% | 121,866 | +112.8% | 0.09% | +1012.5% |
| Q3 2019 | $2,262,000 | -69.4% | 57,257 | -68.2% | 0.01% | -68.0% |
| Q2 2019 | $7,390,000 | +32.6% | 179,902 | +50.3% | 0.02% | +38.9% |
| Q1 2019 | $5,574,000 | +142.1% | 119,687 | +152.3% | 0.02% | +157.1% |
| Q2 2018 | $2,302,000 | +42.3% | 47,435 | +24.4% | 0.01% | +40.0% |
| Q4 2017 | $1,618,000 | +418.6% | 38,121 | +495.6% | 0.01% | +400.0% |
| Q4 2015 | $312,000 | +13.5% | 6,400 | -20.9% | 0.00% | 0.0% |
| Q2 2014 | $275,000 | -65.6% | 8,089 | -65.1% | 0.00% | -75.0% |
| Q1 2014 | $799,000 | – | 23,164 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |